Daniel C Sullivan
Overview
Explore the profile of Daniel C Sullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
2740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gammon S, Cohen A, Lehnert A, Sullivan D, Malyarenko D, Manning H, et al.
Tomography
. 2023 Apr;
9(2):750-758.
PMID: 37104131
Providing method descriptions that are more detailed than currently available in typical peer reviewed journals has been identified as an actionable area for improvement. In the biochemical and cell biology...
2.
McGee K, Hwang K, Sullivan D, Kurhanewicz J, Hu Y, Wang J, et al.
Med Phys
. 2021 Apr;
48(7):e697-e732.
PMID: 33864283
A magnetic resonance (MR) biologic marker (biomarker) is a measurable quantitative characteristic that is an indicator of normal biological and pathogenetic processes or a response to therapeutic intervention derived from...
3.
Fournier L, Costaridou L, Bidaut L, Michoux N, Lecouvet F, de Geus-Oei L, et al.
Eur Radiol
. 2021 Mar;
31(8):6408-6409.
PMID: 33693997
No abstract available.
4.
Avila R, Fain S, Hatt C, Armato 3rd S, Mulshine J, Gierada D, et al.
Clin Imaging
. 2021 Mar;
77:151-157.
PMID: 33684789
As the COVID-19 pandemic impacts global populations, computed tomography (CT) lung imaging is being used in many countries to help manage patient care as well as to rapidly identify potentially...
5.
Fournier L, Costaridou L, Bidaut L, Michoux N, Lecouvet F, de Geus-Oei L, et al.
Eur Radiol
. 2021 Jan;
31(8):6001-6012.
PMID: 33492473
Existing quantitative imaging biomarkers (QIBs) are associated with known biological tissue characteristics and follow a well-understood path of technical, biological and clinical validation before incorporation into clinical trials. In radiomics,...
6.
Byrd D, Brierley J, Baker T, Sullivan D, Gress D
CA Cancer J Clin
. 2020 Nov;
71(2):140-148.
PMID: 33156543
Until recently, cancer registries have only collected cancer clinical stage at diagnosis, before any therapy, and pathological stage after surgical resection, provided no treatment has been given before the surgery,...
7.
Mulshine J, Avila R, Conley E, Devaraj A, Ambrose L, Flanagan T, et al.
JCO Clin Cancer Inform
. 2020 Feb;
4:89-99.
PMID: 32027538
Purpose: To improve outcomes for lung cancer through low-dose computed tomography (LDCT) early lung cancer detection. The International Association for the Study of Lung Cancer is developing the Early Lung...
8.
Das S, McGurk R, Miften M, Mutic S, Bowsher J, Bayouth J, et al.
Med Phys
. 2019 Jun;
46(10):e706-e725.
PMID: 31230358
The use of positron emission tomography (PET) in radiation therapy (RT) is rapidly increasing in the areas of staging, segmentation, treatment planning, and response assessment. The most common radiotracer is...
9.
Keenan K, Biller J, Delfino J, Boss M, Does M, Evelhoch J, et al.
J Magn Reson Imaging
. 2019 Jan;
49(7):e26-e39.
PMID: 30680836
5 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2019.
10.
OConnor J, Aboagye E, Adams J, Aerts H, Barrington S, Beer A, et al.
Nat Rev Clin Oncol
. 2016 Oct;
14(3):169-186.
PMID: 27725679
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection fraction. Other...